Subscribe

Amer Zeidan, MBBS, MHS

Associate Professor
Department of Internal Medicine, Hematology
Yale School of Medicine
Yale University
New Haven, CT

Authored Items

Ask the Expert: COMMANDS Trial Results of First-Line Luspatercept Versus Epoetin Alfa in Transfusion-Dependent Patients With Lower-Risk Myelodysplastic Syndromes
By Amer Zeidan, MBBS, MHS
Supplements

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, monthly TON print publication and TON weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.